This study is the first to document that a histone 2A subfamily member, H2AFJ, has an oncogenic function and is highly expressed in primary tumors of GBM, especially mesenchymal-type GBM, which commonly exhibits a poor TMZ response and unfavorable outcomes in patients. This evidence concerns the gene H2AJ and glioblastoma.